That’s what I’m not able to figure out,” said AI YouTube personality Mo Bitar in a video. The demos are fun, but how accurate ...
OpenAI Announces 'Safety and International Standards Framework' for Next-Generation AI Development and Recursive Self-Improvement (RSI) Article URL: Building standards for the next phase of AI — OpenA ...
AI CTO and systems builder. CTO of Archdesk; founder of Lextron.ai, Inclify and Rejsomat. I write on enterprise AI, agents and Joule Wars. RSI AI refers to artificial intelligence capable of recursive ...
Most of us are guilty of romanticizing the past. Do you long to be the captain of a tall ship? Just as long as you don’t mind weevils in your food, vitamin deficiencies, and death from an ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...